Komori
Daicel (4202) · InitiativeAdvanced

Restructuring unprofitable businesses and locations

First written in FY2021. 7 of 8 entries say "Advanced", first in FY2022. Latest entry: FY2026.

8entries
6years
2from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2021AdvancedFY2022 – FY20262021: 120212022: 220222023: 120232024: 020242025: 120252026: 32026
Same theme, other companies

64 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 177 companies compared. The sentences above are computed from all 177.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「The Company has also pursued selective concentration through a review of its business portfolio, including making 富山フィルタートウ株式会社 a wholly owned subsidiary and transferring its packaging materials and lens businesses.」

    Regarding the rebuilding of the business portfolio, the Company made 富山フィルタートウ a wholly owned subsidiary and transferred its packaging materials and lens businesses.
  2. FY2025AdvancedAnnual report

    「The Company is also undertaking business restructuring through selective concentration, including the establishment of a joint venture through the transfer of the resin compounding business, the transfer of the high-foaming plastics business, and the strengthening of the acetate tow business base through the transfer of a business and the acquisition of an interest in a joint venture.」

    Regarding the restructuring of unprofitable and non-core businesses and the rebuilding of the business portfolio, the Company transferred the resin compounding business and other businesses, established a joint venture, and strengthened the acetate tow business base.
  3. FY2024-Q1AdvancedAnnual report

    「The Other segment reported lower revenue, mainly due to the withdrawal from defense-related businesses.」

    Regarding the restructuring of unprofitable businesses and locations, the withdrawal from defense-related businesses progressed and emerged as a factor behind lower revenue in the Other segment.
  4. FY2023-Q1AdvancedAnnual report

    「The company recognized costs and losses arising in connection with the dissolution of Daicel Safety Systems Korea, Inc. as business restructuring losses.」

    Regarding the restructuring of unprofitable businesses and locations, the Company advanced to the stage of reorganizing the business associated with the dissolution of Daicel Safety Systems Korea, Inc.
  5. FY2022AdvancedAnnual report

    「As part of the restructuring of its business portfolio, the Company is proceeding with its withdrawal from the defense business and the biaxially oriented polystyrene sheet business, while exploring new applications for cellulose acetate, a core product, by leveraging its biomass and biodegradability characteristics to address the Plastic Resource Circulation Act.」

    Regarding the restructuring of unprofitable businesses and locations, the Company entered the stage of proceeding with its withdrawal from the defense business and the biaxially oriented polystyrene sheet business.
  6. FY2021First statedAnnual report

    「Withdrawal from unprofitable businesses, consolidation and closure of unprofitable locations, and work-style reform」

    As measures to address the economic downturn, the Company explicitly stated that it would withdraw from unprofitable businesses and consolidate or close unprofitable locations.
Moved together

"Profit allocation combining performance-linked dividends and retained earnings" moved the same way as this thread, in the same document, in 7 of its 8 moves.

766666★123456
  1. ★This thread
  2. 1Profit allocation combining performance-linked dividends and retained earnings7×
  3. 2Strengthening collaboration with business partners6×
  4. 3Strengthening Technology and Product Discovery and Commercialization Capabilities6×
  5. 4Building the healthcare business6×
  6. 5Development of functional materials in the electronics and medical fields6×
  7. 6Selective focus and concentrated resource allocation toward growth BUs through BU management6×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Daicel's next results are scheduled for 2026-11-05. Read the earnings preview It last moved in the Earnings presentation of 2026-05-22: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.